FDA Approves Long-Acting COPD Inhaler
(MedPage Today) -- The FDA approved another once-daily bronchodilator, olodaterol (Striverdi Respimat), for maintenance treatment of chronic obstructive pulmonary disease (COPD).
Source: MedPage Today Emergency Medicine - Category: Emergency Medicine Source Type: news
More News: Chronic Obstructive Pulmonary | Emergency Medicine